Strive Inc. has filed a Registration Statement on Form S-4 with the SEC in connection with a proposed transaction involving the issuance of its Class A common stock to the stockholders of Semler Scientific. The transaction includes the distribution of an information statement, proxy statement, and prospectus to Semler Scientific shareholders to seek their approval. The filing outlines potential risks such as increased costs, delays, management distraction, possible dilution from the issuance of additional shares, and potential changes in customer or employee relationships as a result of the transaction. Further details about the interests of directors and executive officers from both companies, as well as information on security ownership, are provided in the materials filed with the SEC.